EUVIMEDEUVIMED entdecken
Crossref

Rational design of PLA-based ASDs for pharmaceutical 3D printing: Insights from phase diagram modeling

Alma Lucia Villela Zumaya, Anton Iemtsev, Michal Fulem, Fatima Hassouna

European Journal of Pharmaceutics and Biopharmaceutics · 2025

DOI: 10.1016/j.ejpb.2025.114657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Alma Lucia Villela Zumaya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Polyesters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Vysoká Škola Chemicko-technologická v Praze, Grantová Agentura České Republiky.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integration of 3D printing into the pharmaceutical sciences opens new possibilities for personalized medicine. Poly(lactide) (PLA), a biodegradable and biocompatible polymer, is highly suitable for biomedical applications, particularly in the context of 3D printing. However, its processability often requires the addition of plasticizers. This study investigates the use of phase diagram modeling as a tool to guide the rational selection of plasticizers and to assess their impact on the thermodynamic and kinetic stability of PLA-based amorphous solid dispersions (ASDs) containing active pharmaceutical ingredients (APIs). Thermodynamic stability against API recrystallization was predicted based on the API solubility in PLA and Plasticizer-PLA carriers using the Conductor-like Screening Model for Real Solvents (COSMO-RS), while the kinetic stability of the ASDs was evaluated by modeling the glass transition temperatures of the mixtures. Two APIs, indomethacin (IND) and naproxen (NAP), with differing glass-forming abilities (i.e., recrystallization tendencies), and three plasticizers, triacetin (TA), triethyl citrate (TEC), and poly(L-lactide-co-caprolactone) (PLCL), were selected for investigation. The physical stability of ASD formulations containing 9 wt% API and plasticizer to PLA in two ratios, 10:81 and 20:71 w/w %, was monitored over time using differential scanning calorimetry and X-ray powder diffraction and compared with phase diagram predictions. All formulations were predicted to be thermodynamically unstable; however, those containing no plasticizer or with TEC and TA at 10 wt% were predicted to exhibit some degree of kinetic stability. Long-term physical studies corroborated these predictions. The correlation between the predicted phase behavior and long-term physical stability highlights the potential of phase diagram modeling as a tool for the rational design of ASDs in pharmaceutical 3D printing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Printing, Three-DimensionalPolyestersPlasticizersSolubilityDrug StabilityCrystallizationNaproxenChemistry, PharmaceuticalIndomethacinDrug CompoundingThermodynamicsTriacetinCitratesDrug DesignCalorimetry, Differential ScanningKineticsPhase Transition

Stichwörter der Autor:innen

3D printingActive pharmaceutical ingredientAmorphous solid dispersionCOSMO-RSPLAPersonalized medicinePhase diagramPlasticizers

Substanzen

poly(lactide)PlasticizersPolyestersNaproxenIndomethacinTriacetinethyl citrateCitrates

Autor:innen und Institutionen

  • Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic.
  • Department of Physical Chemistry, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic.
  • Department of Physical Chemistry, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Electronic address: fulemm@vscht.cz.
  • Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Electronic address: fatima.hassouna@vscht.cz.

Förderung

  • Vysoká Škola Chemicko-technologická v Praze
  • Grantová Agentura České Republiky

Zitieren

APA

Zumaya, A. L. V., Iemtsev, A., Fulem, M., & Hassouna, F. (2025). Rational design of PLA-based ASDs for pharmaceutical 3D printing: Insights from phase diagram modeling. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114657

Vancouver

Zumaya ALV, Iemtsev A, Fulem M, Hassouna F. Rational design of PLA-based ASDs for pharmaceutical 3D printing: Insights from phase diagram modeling. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2025.114657

BibTeX
@article{Zumaya2025,
  author = {Zumaya, Alma Lucia Villela and Iemtsev, Anton and Fulem, Michal and Hassouna, Fatima},
  title = {Rational design of PLA-based ASDs for pharmaceutical 3D printing: Insights from phase diagram modeling},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2025},
  doi = {10.1016/j.ejpb.2025.114657}
}
Kostenlos starten →